Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. S-3/A Offering Registration Statement
  2. S-3 Offering Registration Statement
  3. DEF 14A Proxy Proxy Statement
  4. SC 13G Stake Amended Statement of Ownership
  5. 10-Q Report Quarterly Report
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 8-K Event Material agreement · Executive or director change · Regulation FD disclosure

Page 8 of 19 · 370 filings